STIMULATION OF OSTEOCLAST DIFFERENTIATION IN VITRO BY MOUSE ONCOSTATIN M, LEUKAEMIA INHIBITORY FACTOR, CARDIOTROPHIN-1 AND INTERLEUKIN 6: SYNERGY WITH DEXAMETHASONE

This publication has 49 references indexed in Scilit:

• STAT3 Activation in Stromal/Osteoblastic Cells Is Required for Induction of the Receptor Activator of NF-κB Ligand and Stimulation of Osteoclastogenesis by gp130-utilizing Cytokines or Interleukin-1 but Not 1,25-Dihydroxyvitamin D3 or Parathyroid Hormone
  Journal of Biological Chemistry, 1999
• CYTOKINES, GROWTH FACTORS AND OSTEOCLASTS
  Cytokine, 1998
• ONCOSTATIN M STIMULATES MACROPHAGE-POLYKARYON FORMATION IN LONG-TERM HUMAN BONE-MARROW CULTURES
  Cytokine, 1998
• Regulation of Osteoclast Function
  Journal of Bone and Mineral Research, 1997
• The role of gp130-mediated signals in osteoclast development: regulation of interleukin 11 production by osteoblasts and distribution of its receptor in bone marrow cultures.
  The Journal of Experimental Medicine, 1996
• Cortisol Increases Interstitial Collagenase Expression in Osteoblasts by Post-transcriptional Mechanisms
  Published by Elsevier ,1995
• Glucocorticoid regulation of calcitonin receptor in mouse osteoclast-like multinucleated cells
  Journal of Bone and Mineral Research, 1994
• Interleukin-11: a new cytokine critical for osteoclast development.
  Journal of Clinical Investigation, 1994
• Increased Osteoclast Development After Estrogen Loss: Mediation by Interleukin-6
  Science, 1992
• Up‐regulation of the interleukin‐6‐signal transducing protein (gp130) by interleukin‐6 and dexamethasone in HepG2 cells
  FEBS Letters, 1992